Growth Metrics

Guardant Health (GH) Capital Expenditures (2017 - 2026)

Guardant Health's Capital Expenditures history spans 9 years, with the latest figure at $27.8 million for Q4 2025.

  • On a quarterly basis, Capital Expenditures rose 47.54% to $27.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $48.3 million, a 37.68% increase, with the full-year FY2025 number at $48.3 million, up 37.68% from a year prior.
  • Capital Expenditures hit $27.8 million in Q4 2025 for Guardant Health, up from $10.4 million in the prior quarter.
  • Over the last five years, Capital Expenditures for GH hit a ceiling of $27.8 million in Q4 2025 and a floor of -$18.7 million in Q3 2021.
  • Historically, Capital Expenditures has averaged $5.3 million across 5 years, with a median of $5.4 million in 2024.
  • Biggest five-year swings in Capital Expenditures: soared 544.43% in 2021 and later plummeted 1686.52% in 2023.
  • Tracing GH's Capital Expenditures over 5 years: stood at -$697000.0 in 2021, then rose by 10.62% to -$623000.0 in 2022, then plummeted by 1686.52% to -$11.1 million in 2023, then skyrocketed by 269.59% to $18.9 million in 2024, then soared by 47.54% to $27.8 million in 2025.
  • Business Quant data shows Capital Expenditures for GH at $27.8 million in Q4 2025, $10.4 million in Q3 2025, and $5.6 million in Q2 2025.